Pharmaceutical composition
AssigneeMRC Holdings Pty Limited
InventorDavid Morris
Life of this patent
Estimating the term…
Abstract
The present invention is concerned with a pharmaceutical composition suitable for the treatment of cancer and in particular with a pharmaceutical composition containing vitamin D or a precursor, analogue or metabolite thereof and the use of these compositions in the treatment of a tumor in a subject.
Claims15
A pharmaceutical composition suitable for use in the treatment of a tumor in an organ by regional delivery of the composition to the organ, wherein the composition consists essentially of a pharmaceutically acceptable lipid comprising a vitamin D compound and wherein the concentration of the vitamin D compound in the composition is greater than about 1×10−7 mole per liter to less than 1×10−3 mole per liter.
Dependencies are inferred from the claim text.